Abstract
The proton-coupled amino acid transporter PAT1 (SLC36A1) is an intestinal carrier of L-proline, L-alanine and glycine. PAT1 has also been shown to transport pharmacologically active substances such as GABA, vigabatrin, δ-aminolevulinic acid and gaboxadol. The present review will discuss if the proton-coupled amino acid transporter PAT1 (SLC36A1) may be a relevant transporter for pharmaceutical exploitation. Research investigating this from both in vitro and in vivo perspectives will be highlighted. Furthermore we’ll review the current knowledge about the structure-translocation relationship for PAT1 and provide an overview of pharmacological active substances, which are substrates for PAT1 along with examples of formulation strategies aimed at exploiting the transport activity of PAT1.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
